Mixtard 30 HM

Mixtard 30 HM is a biphasic insulin designed to help manage diabetes. It combines both short-acting (regular) and intermediate-acting (NPH) insulin components. The “30” in its name indicates that it contains 30% regular insulin, and “HM” stands for human insulin mixture.

This insulin is administered via a pen device, making it convenient and easy to use. It is typically prescribed for people with type 1 diabetes, where the body does not produce insulin, and for some individuals with type 2 diabetes who cannot control their blood sugar levels with oral medications alone.

The short-acting component of Mixtard 30 HM works quickly to reduce high blood sugar levels after meals, while the intermediate-acting component provides a steady background level of insulin throughout the day and night. This helps maintain stable blood sugar levels between meals and during periods of fasting.

Healthcare providers may adjust the dosing regimen of Mixtard 30 HM to suit individual patient needs, taking into account factors such as diet, activity level, and blood sugar monitoring. The primary benefit of Mixtard 30 HM is its ability to lower and regulate blood sugar levels, preventing hyperglycemia (high blood sugar) and its associated complications.

For those who need to manage their diabetes effectively, Mixtard 30 HM offers a reliable and customizable solution. Always follow your healthcare provider’s instructions regarding insulin use to ensure the best results.